[Emerging infectious diseases--MRSA infections].
Yokoyama
T
T
Takesue
Y
Y
Hiyama
E
E
Murakami
Y
Y
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins; D003030:Coagulase / Q000378:metabolism; D004768:Enterotoxins / Q000378:metabolism; D006801:Humans; D016106:Methicillin Resistance; D012772:Shock, Septic / Q000209:etiology; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000145:classification / Q000472:pathogenicity; D018089:Superantigens; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D003030:Coagulase; D004768:Enterotoxins; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal; D014640:Vancomycin